Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunotherapy with B28, an antibody to Aβ oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in mice.

Cell reports·2026
Same author

Aβ Aggregates Bind the U1 Spliceosomal Ribonucleoprotein in Alzheimer Disease Brain.

bioRxiv : the preprint server for biology·2026
Same author

Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8<sup>+</sup> T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trial.

npj aging·2026
Same author

Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

Nature medicine·2026
Same author

Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adults.

Nature communications·2026
Same author

Anti-amyloid antibody equilibrium binding to Aβ aggregates from human Alzheimer's disease brain.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Jun 9, 2026

Quantitative Measurement of &#947;-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

Identification of beta-secretase (BACE1) substrates using quantitative proteomics.

Matthew L Hemming1, Joshua E Elias, Steven P Gygi

  • 1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.

Plos One
|December 31, 2009
PubMed
Summary

Researchers identified 68 new substrates for Beta-site APP cleaving enzyme 1 (BACE1), an enzyme implicated in Alzheimer's disease. This discovery broadens understanding of BACE1's roles beyond amyloid-beta production.

More Related Videos

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)
06:45

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)

Published on: June 15, 2018

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
09:00

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

Related Experiment Videos

Last Updated: Jun 9, 2026

Quantitative Measurement of &#947;-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)
06:45

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)

Published on: June 15, 2018

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
09:00

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

Area of Science:

  • Biochemistry
  • Neuroscience
  • Proteomics

Background:

  • Beta-site APP cleaving enzyme 1 (BACE1) is a key enzyme in Alzheimer's disease pathogenesis, responsible for amyloid-beta production.
  • Emerging research highlights BACE1's crucial roles in myelination and cognitive functions, though its substrates in these processes remain largely unknown.
  • Previous substrate identification relied on candidate-based approaches, limiting the discovery of novel BACE1 targets.

Purpose of the Study:

  • To identify novel substrates of BACE1 using an unbiased proteomic approach.
  • To expand the understanding of BACE1's cellular functions beyond amyloid-beta generation.
  • To investigate potential mechanisms of toxicity associated with BACE1 inhibition.

Main Methods:

  • Quantitative proteomic analysis of human epithelial cell lines engineered to stably express BACE1.
  • Validation of identified putative substrates in a cell culture system.
  • Analysis of protein topology and functional roles of identified substrates.

Main Results:

  • Identification of 68 putative BACE1 substrates.
  • The majority of identified substrates are type I transmembrane proteins, with some type II and GPI-linked proteins also found.
  • A significant number of substrates are involved in intercellular communication, receptor function, and have roles in the nervous system and other organs.
  • No consistent sequence motif was identified to predict BACE1 cleavage sites.

Conclusions:

  • This study significantly expands the known repertoire of BACE1 substrates.
  • The identified substrates suggest novel roles for BACE1 in intercellular communication and nervous system function.
  • Findings provide insights into potential off-target effects and toxicity mechanisms of BACE1 inhibitors.